Alzheimer's - McKnight's Senior Living

Alzheimer’s

Lumosity to pay $2 million to settle deceptive advertising charges

Lumosity has agreed to pay $2 million to settle Federal Trade Commission charges that it deceived consumers with unfounded claims that its “brain games” can reduce or delay cognitive impairment associated with age and other serious health conditions. The company said that it continues to stand behind its products.

Hillary Clinton

Clinton shares Alzheimer’s plans

Democratic presidential candidate Hillary Clinton unveiled a plan Dec. 22 to invest $2 billion per year to prevent, treat and make possible a cure for Alzheimer’s disease by the year 2025 if she is elected president of the United States. Advocacy groups applauded the plan, calling it “bold” and “aggressive,” and they called on other candidates to show the same commitment.

Photo by Raija Törrönen

The other drugs that should concern senior living

Much attention has been paid to reducing the off-label use of antipsychotic medications in older adults, but researchers say the inappropriate use of another class of psychotropic drugs is even more common—and just as troubling because of its potential to lead to falls and the hold it has on those who take it.

Next post in News